Global Digital Therapeutics for Endocrine System Diseases Supply, Demand and Key Producers, 2023-2029

February 2023 | 77 pages | ID: G4F9D1AAC5F3EN
GlobalInfoResearch

Abstracts

Digital Therapeutics for Endocrine System Diseases are software program-driven, evidence-based interventions to treat, manage, or prevent endocrine system diseases.

This report studies the global Digital Therapeutics for Endocrine System Diseases demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Digital Therapeutics for Endocrine System Diseases, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Digital Therapeutics for Endocrine System Diseases that contribute to its increasing demand across many markets.

The global Digital Therapeutics for Endocrine System Diseases market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study

Global Digital Therapeutics for Endocrine System Diseases total market, 2018-2029, (USD Million)

Global Digital Therapeutics for Endocrine System Diseases total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Digital Therapeutics for Endocrine System Diseases total market, key domestic companies and share, (USD Million)

Global Digital Therapeutics for Endocrine System Diseases revenue by player and market share 2018-2023, (USD Million)

Global Digital Therapeutics for Endocrine System Diseases total market by Type, CAGR, 2018-2029, (USD Million)

Global Digital Therapeutics for Endocrine System Diseases total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Digital Therapeutics for Endocrine System Diseases market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Livongo, SHANGYI and EnteroMedics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Digital Therapeutics for Endocrine System Diseases market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Digital Therapeutics for Endocrine System Diseases Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Digital Therapeutics for Endocrine System Diseases Market, Segmentation by Type

• Prevention
• Management
• Treatment

Global Digital Therapeutics for Endocrine System Diseases Market, Segmentation by Application

• Diabetes
• Metabolic Syndrome
• Obesity
• Other

Companies Profiled:

• Livongo
• SHANGYI
• EnteroMedics

Key Questions Answered

1. How big is the global Digital Therapeutics for Endocrine System Diseases market?

2. What is the demand of the global Digital Therapeutics for Endocrine System Diseases market?

3. What is the year over year growth of the global Digital Therapeutics for Endocrine System Diseases market?

4. What is the total value of the global Digital Therapeutics for Endocrine System Diseases market?

5. Who are the major players in the global Digital Therapeutics for Endocrine System Diseases market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Digital Therapeutics for Endocrine System Diseases Introduction
1.2 World Digital Therapeutics for Endocrine System Diseases Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Digital Therapeutics for Endocrine System Diseases Total Market by Region (by Headquarter Location)
  1.3.1 World Digital Therapeutics for Endocrine System Diseases Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Digital Therapeutics for Endocrine System Diseases Market Size (2018-2029)
  1.3.3 China Digital Therapeutics for Endocrine System Diseases Market Size (2018-2029)
  1.3.4 Europe Digital Therapeutics for Endocrine System Diseases Market Size (2018-2029)
  1.3.5 Japan Digital Therapeutics for Endocrine System Diseases Market Size (2018-2029)
  1.3.6 South Korea Digital Therapeutics for Endocrine System Diseases Market Size (2018-2029)
  1.3.7 ASEAN Digital Therapeutics for Endocrine System Diseases Market Size (2018-2029)
  1.3.8 India Digital Therapeutics for Endocrine System Diseases Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Digital Therapeutics for Endocrine System Diseases Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Digital Therapeutics for Endocrine System Diseases Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Digital Therapeutics for Endocrine System Diseases Consumption Value (2018-2029)
2.2 World Digital Therapeutics for Endocrine System Diseases Consumption Value by Region
  2.2.1 World Digital Therapeutics for Endocrine System Diseases Consumption Value by Region (2018-2023)
  2.2.2 World Digital Therapeutics for Endocrine System Diseases Consumption Value Forecast by Region (2024-2029)
2.3 United States Digital Therapeutics for Endocrine System Diseases Consumption Value (2018-2029)
2.4 China Digital Therapeutics for Endocrine System Diseases Consumption Value (2018-2029)
2.5 Europe Digital Therapeutics for Endocrine System Diseases Consumption Value (2018-2029)
2.6 Japan Digital Therapeutics for Endocrine System Diseases Consumption Value (2018-2029)
2.7 South Korea Digital Therapeutics for Endocrine System Diseases Consumption Value (2018-2029)
2.8 ASEAN Digital Therapeutics for Endocrine System Diseases Consumption Value (2018-2029)
2.9 India Digital Therapeutics for Endocrine System Diseases Consumption Value (2018-2029)

3 WORLD DIGITAL THERAPEUTICS FOR ENDOCRINE SYSTEM DISEASES COMPANIES COMPETITIVE ANALYSIS

3.1 World Digital Therapeutics for Endocrine System Diseases Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Digital Therapeutics for Endocrine System Diseases Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Digital Therapeutics for Endocrine System Diseases in 2022
  3.2.3 Global Concentration Ratios (CR8) for Digital Therapeutics for Endocrine System Diseases in 2022
3.3 Digital Therapeutics for Endocrine System Diseases Company Evaluation Quadrant
3.4 Digital Therapeutics for Endocrine System Diseases Market: Overall Company Footprint Analysis
  3.4.1 Digital Therapeutics for Endocrine System Diseases Market: Region Footprint
  3.4.2 Digital Therapeutics for Endocrine System Diseases Market: Company Product Type Footprint
  3.4.3 Digital Therapeutics for Endocrine System Diseases Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Digital Therapeutics for Endocrine System Diseases Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Digital Therapeutics for Endocrine System Diseases Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Digital Therapeutics for Endocrine System Diseases Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Digital Therapeutics for Endocrine System Diseases Consumption Value Comparison
  4.2.1 United States VS China: Digital Therapeutics for Endocrine System Diseases Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Digital Therapeutics for Endocrine System Diseases Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Digital Therapeutics for Endocrine System Diseases Companies and Market Share, 2018-2023
  4.3.1 United States Based Digital Therapeutics for Endocrine System Diseases Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Digital Therapeutics for Endocrine System Diseases Revenue, (2018-2023)
4.4 China Based Companies Digital Therapeutics for Endocrine System Diseases Revenue and Market Share, 2018-2023
  4.4.1 China Based Digital Therapeutics for Endocrine System Diseases Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Digital Therapeutics for Endocrine System Diseases Revenue, (2018-2023)
4.5 Rest of World Based Digital Therapeutics for Endocrine System Diseases Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Digital Therapeutics for Endocrine System Diseases Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Digital Therapeutics for Endocrine System Diseases Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Digital Therapeutics for Endocrine System Diseases Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Prevention
  5.2.2 Management
  5.2.3 Treatment
5.3 Market Segment by Type
  5.3.1 World Digital Therapeutics for Endocrine System Diseases Market Size by Type (2018-2023)
  5.3.2 World Digital Therapeutics for Endocrine System Diseases Market Size by Type (2024-2029)
  5.3.3 World Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Digital Therapeutics for Endocrine System Diseases Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Diabetes
  6.2.2 Metabolic Syndrome
  6.2.3 Obesity
  6.2.4 Other
  6.2.5 Other
6.3 Market Segment by Application
  6.3.1 World Digital Therapeutics for Endocrine System Diseases Market Size by Application (2018-2023)
  6.3.2 World Digital Therapeutics for Endocrine System Diseases Market Size by Application (2024-2029)
  6.3.3 World Digital Therapeutics for Endocrine System Diseases Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Livongo
  7.1.1 Livongo Details
  7.1.2 Livongo Major Business
  7.1.3 Livongo Digital Therapeutics for Endocrine System Diseases Product and Services
  7.1.4 Livongo Digital Therapeutics for Endocrine System Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Livongo Recent Developments/Updates
  7.1.6 Livongo Competitive Strengths & Weaknesses
7.2 SHANGYI
  7.2.1 SHANGYI Details
  7.2.2 SHANGYI Major Business
  7.2.3 SHANGYI Digital Therapeutics for Endocrine System Diseases Product and Services
  7.2.4 SHANGYI Digital Therapeutics for Endocrine System Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 SHANGYI Recent Developments/Updates
  7.2.6 SHANGYI Competitive Strengths & Weaknesses
7.3 EnteroMedics
  7.3.1 EnteroMedics Details
  7.3.2 EnteroMedics Major Business
  7.3.3 EnteroMedics Digital Therapeutics for Endocrine System Diseases Product and Services
  7.3.4 EnteroMedics Digital Therapeutics for Endocrine System Diseases Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 EnteroMedics Recent Developments/Updates
  7.3.6 EnteroMedics Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Digital Therapeutics for Endocrine System Diseases Industry Chain
8.2 Digital Therapeutics for Endocrine System Diseases Upstream Analysis
8.3 Digital Therapeutics for Endocrine System Diseases Midstream Analysis
8.4 Digital Therapeutics for Endocrine System Diseases Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Digital Therapeutics for Endocrine System Diseases Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Digital Therapeutics for Endocrine System Diseases Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Digital Therapeutics for Endocrine System Diseases Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Digital Therapeutics for Endocrine System Diseases Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Digital Therapeutics for Endocrine System Diseases Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Digital Therapeutics for Endocrine System Diseases Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Digital Therapeutics for Endocrine System Diseases Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Digital Therapeutics for Endocrine System Diseases Players in 2022
Table 12. World Digital Therapeutics for Endocrine System Diseases Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Digital Therapeutics for Endocrine System Diseases Company Evaluation Quadrant
Table 14. Head Office of Key Digital Therapeutics for Endocrine System Diseases Player
Table 15. Digital Therapeutics for Endocrine System Diseases Market: Company Product Type Footprint
Table 16. Digital Therapeutics for Endocrine System Diseases Market: Company Product Application Footprint
Table 17. Digital Therapeutics for Endocrine System Diseases Mergers & Acquisitions Activity
Table 18. United States VS China Digital Therapeutics for Endocrine System Diseases Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Digital Therapeutics for Endocrine System Diseases Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Digital Therapeutics for Endocrine System Diseases Companies, Headquarters (States, Country)
Table 21. United States Based Companies Digital Therapeutics for Endocrine System Diseases Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Digital Therapeutics for Endocrine System Diseases Revenue Market Share (2018-2023)
Table 23. China Based Digital Therapeutics for Endocrine System Diseases Companies, Headquarters (Province, Country)
Table 24. China Based Companies Digital Therapeutics for Endocrine System Diseases Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Digital Therapeutics for Endocrine System Diseases Revenue Market Share (2018-2023)
Table 26. Rest of World Based Digital Therapeutics for Endocrine System Diseases Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Digital Therapeutics for Endocrine System Diseases Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Digital Therapeutics for Endocrine System Diseases Revenue Market Share (2018-2023)
Table 29. World Digital Therapeutics for Endocrine System Diseases Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Digital Therapeutics for Endocrine System Diseases Market Size by Type (2018-2023) & (USD Million)
Table 31. World Digital Therapeutics for Endocrine System Diseases Market Size by Type (2024-2029) & (USD Million)
Table 32. World Digital Therapeutics for Endocrine System Diseases Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Digital Therapeutics for Endocrine System Diseases Market Size by Application (2018-2023) & (USD Million)
Table 34. World Digital Therapeutics for Endocrine System Diseases Market Size by Application (2024-2029) & (USD Million)
Table 35. Livongo Basic Information, Area Served and Competitors
Table 36. Livongo Major Business
Table 37. Livongo Digital Therapeutics for Endocrine System Diseases Product and Services
Table 38. Livongo Digital Therapeutics for Endocrine System Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Livongo Recent Developments/Updates
Table 40. Livongo Competitive Strengths & Weaknesses
Table 41. SHANGYI Basic Information, Area Served and Competitors
Table 42. SHANGYI Major Business
Table 43. SHANGYI Digital Therapeutics for Endocrine System Diseases Product and Services
Table 44. SHANGYI Digital Therapeutics for Endocrine System Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. SHANGYI Recent Developments/Updates
Table 46. EnteroMedics Basic Information, Area Served and Competitors
Table 47. EnteroMedics Major Business
Table 48. EnteroMedics Digital Therapeutics for Endocrine System Diseases Product and Services
Table 49. EnteroMedics Digital Therapeutics for Endocrine System Diseases Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 50. Global Key Players of Digital Therapeutics for Endocrine System Diseases Upstream (Raw Materials)
Table 51. Digital Therapeutics for Endocrine System Diseases Typical Customers
List of Figure
Figure 1. Digital Therapeutics for Endocrine System Diseases Picture
Figure 2. World Digital Therapeutics for Endocrine System Diseases Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Digital Therapeutics for Endocrine System Diseases Total Market Size (2018-2029) & (USD Million)
Figure 4. World Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Digital Therapeutics for Endocrine System Diseases Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Digital Therapeutics for Endocrine System Diseases Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Digital Therapeutics for Endocrine System Diseases Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Digital Therapeutics for Endocrine System Diseases Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Digital Therapeutics for Endocrine System Diseases Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Digital Therapeutics for Endocrine System Diseases Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Digital Therapeutics for Endocrine System Diseases Revenue (2018-2029) & (USD Million)
Figure 13. Digital Therapeutics for Endocrine System Diseases Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Digital Therapeutics for Endocrine System Diseases Consumption Value (2018-2029) & (USD Million)
Figure 16. World Digital Therapeutics for Endocrine System Diseases Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Digital Therapeutics for Endocrine System Diseases Consumption Value (2018-2029) & (USD Million)
Figure 18. China Digital Therapeutics for Endocrine System Diseases Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Digital Therapeutics for Endocrine System Diseases Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Digital Therapeutics for Endocrine System Diseases Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Digital Therapeutics for Endocrine System Diseases Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Digital Therapeutics for Endocrine System Diseases Consumption Value (2018-2029) & (USD Million)
Figure 23. India Digital Therapeutics for Endocrine System Diseases Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Digital Therapeutics for Endocrine System Diseases by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Digital Therapeutics for Endocrine System Diseases Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Digital Therapeutics for Endocrine System Diseases Markets in 2022
Figure 27. United States VS China: Digital Therapeutics for Endocrine System Diseases Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Digital Therapeutics for Endocrine System Diseases Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Digital Therapeutics for Endocrine System Diseases Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Type in 2022
Figure 31. Prevention
Figure 32. Management
Figure 33. Treatment
Figure 34. World Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Type (2018-2029)
Figure 35. World Digital Therapeutics for Endocrine System Diseases Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Application in 2022
Figure 37. Diabetes
Figure 38. Metabolic Syndrome
Figure 39. Obesity
Figure 40. Other
Figure 41. Digital Therapeutics for Endocrine System Diseases Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source